Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Malaya
Patients diagnosed with breast cancer will be supplemented with either curcumin or placebo for a minimum period of 2 weeks and may be extended up to 4 weeks prior to their surgery.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with operable breast cancer
Life expectancy of at least 3 months
Adequate organ function
No allergy to curcumin
Provides consent to participate in trial and adhere to the study protocol
You may not be if
Receiving concomitant radiotherapy, hormonal, immune therapy or other investigational drugs
Uncontrolled concurrent illness
Patient of anti platelet medications
Pregnant / breast feeding
Patients who are unable or unwilling to take curcumin, herbal remedies, or non-prescription medications
Patients with bleeding tendency, bleeding disorders and abnormal bleeding/clotting profile
Clareo Health | Effect of Preoperative Curcumin in Breast Cancer Patients
